Hub-WHO Joint G7 Progress Report Published

Since 2021, G7 Finance and Health Ministers have reinforced their commitment to accelerating antimicrobial resistance (AMR) strategies, addressing the antibiotic pipeline and market failure, preserving access to essential antibiotics, and enhancing research and development (R&D) to bring new antibacterials to market, particularly for the vulnerable populations most impacted by AMR. The Global AMR R&D Hub and the World Health Organisation (WHO) presented a progress report to G7 Health and Finance Ministers in May 2022, with an update in 2023.

The current report provides an annual update on the financial landscape for antibacterial innovation, tracks country-by -country progress, and outlines key actions for the coming year to support G7 policy and activities.


Curious about more?

You can sign up for our newsletter here. By subscribing, you automatically provide your consent for the use of your data in accordance with our privacy policy.

This field is for validation purposes and should be left unchanged.

Latest news

Go to all news
Dynamic Dashboard